Indaptus Therapeutics shares soar on patent allowance
15/09/2021 15:26
** Shares in Indaptus Therapeutics Inc INDP.O up 193.1% at
$20.72 after hitting its highest level since March 16 in early
session trading on a notice of allowance for patent announcement
** The patent “Methods of Treatment of Infections Using
Bacteria” provides broad protection for application of Indaptus'
technology alone and in combination with other care for
treatment, inhibition of hepatitis B virus (HBV) and human
immunodeficiency virus (HIV) infections urn:newsml:reuters.com:*:nGNX2WVxMz
** INDP CEO Jeffrey Meckler says in statement that notice of
allowance gives it optionality to pursue its technology in viral
diseases and/or to partner for further development
** Trading volume in INDP already above 55 mln shares vs
10-day moving average of 159,165 shares
(Reporting By Sinéad Carew)
((sinead.carew@thomsonreuters.com; +1 (646) 223 6186; Reuters
Messaging: sinead.carew.thomsonreuters.com@reuters.net))